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EPIGRAPH
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but, it can be challenged. Every individual is born as many individuals and dies as one.”
― Martin Heidegger

*Note: This quote was adapted to be inclusive to all genders.
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ABSTRACT
SPATIOTEMPORAL METABOLIC MODELING OF PSEUDOMONAS
AERUGINOSA BIOFILM EXPANSION
SEPTEMBER 2021
ROBERT L. SOURK II, B.S. IOWA STATE UNIVERSITY
MSCHE, UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by Michael Henson
Spatiotemporal metabolic modeling of microbial metabolism is a step closer to
achieving higher dimensionalities in numerical studies (in silico) of biofilm maturation.
Dynamic Flux Balance Analysis (DFBA) is an advanced modeling technique because this
method incorporates Genome Scale Metabolic Modeling (GSMM) to compute the
biomass growth rate and metabolite fluxes. Biofilm thickness is pertinent because this
variable of biofilm maturation can be measured in a laboratory (in vitro). Pseudomonas
aeruginosa (P. aeruginosa) is the model bacterium used in this computational model
based on previous research conducted by Dr. Michael Henson, available GSMMs, and
the societal significance of patients suffering from P. aeruginosa airway infections.
Spatiotemporal Flux Balance Analysis (SFBA) will be the computational method used in
this thesis to simulate biofilm growth. Another level of accuracy will be introduced to
SFBA which is a dynamic finite difference grid that will vary relative to the biofilm’s
velocity of expansion/contraction. This novel idea is governed by a differential equation
that defines the biofilm’s velocity and updates the spatial dependency of the finite
difference grid which has never been done while utilizing GSMM. Environmental
conditions (bulk concentrations of metabolites) are altered to investigate how varying
nutrients (glucose, oxygen, lactate, nitrate) affected biofilm maturation.
iii
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CHAPTER 1
INTRODUCTION
1.1- Lung Infections in Cystic Fibrosis Patients caused by Pseudomonas aeruginosa
The simplest scientific definition of a bacterium is a single cellular
microorganism (prokaryote) with simple internal structures that lack a nucleus and range
in size from 0.2–2.0 nanometers (nm) [1, 2]. Bacteria’s size allows these microorganisms
to flourish in their environments by forming microcolonies, and this can lead to biofilm
formation [3, 4]. The formation of biofilms is an active research area for chemical
engineer’s because transport phenomena governs’ biofilm growth. Studying biofilm
formation and maturation of Pseudomonas aeruginosa (P. aeruginosa) which occurs
within the lungs of patients that suffer from Cystic Fibrosis (CF) is an area that is
currently under academic research [5, 6].
Short lifespans of CF patients are plagued with symptoms such as frequent lung
infections (pneumonia or bronchitis) and shortness of breath [7]. CF is caused by a
mutation the gene Cystic Fibrosis Transmembrane Conductance Regulator (CTFR), and
this gene controls the flow of salts and fluids in the cell [8, 9]. Mutations in the CTFR
gene does not allow mucus from the lungs to be secreted, and this environment is ideal
for P. aeruginosa which is often the cause for progressive and severe lung disease in CF
patients [10, 11]. P. aeruginosa forms a biofilm in the lungs and is detrimental because
the lungs cannot secrete contaminated sputum and has shown an increased tolerance to
antibiotics [12]. Studying P. aeruginosa’s biofilm growth is done using various
techniques such as in vitro and in silico studies.
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1.2 – In Vitro Studies of Biofilms
In vitro methods have been used to study biofilms and consist of three
approaches: Closed, Open, and Microcosms [13, 14]. Open studies are dynamic and
allow for the quantification of wastes, metabolic byproducts, and dispersed or dead
bacteria [13]. The dynamical nature of biofilm growth is governed by transport
phenomena, and in vitro methods collect data used for in silico modeling. In vitro
methods allow researchers to obtain the complete picture of the necessary steps that lead
to biofilm growth.
Open studies of P. aeruginosa biofilms have shown that biofilm formation on
biotic and abiotic surfaces give resistant to the host’s immune defenses and antibiotic
medications [15, 16]. These studies have been motivated by CF and has given rise to an
understanding of the environmental conditions that contribute to microcolony formation.
Environmental factors alter P. aeruginosa‘s metabolism, ultimately causing the bacteria
to flourish or perish. Specifically, glucose and lactate are carbon sources metabolized by
P. aeruginosa and have shown nutrient diversity that aid in the survival of the bacterium
[17, 18]. Glucose and lactate are converted to pyruvate which is then metabolized based
on the cellular environment (anaerobic/aerobic) [19, 20].
These methods have been important to the field of biofilm research; however,
they are also critiqued due to being oversimplistic [13]. One way in which in vitro
methods are unrealistic is because they are not able to estimate the concentration
gradients of most metabolites throughout the biofilm’s matrix. To quantify the
concentration throughout a biofilm’s matrix this is done via a mathematical model
because of the size of a biofilm [21]. On average biofilm thickness ranges from 50-400
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microns and trying to measure the concentration at this scale with current technologies is
impractical [22]. However, microsensors have been used to measure the local oxygen
concentration in a defined region of a biofilm [23, 24].
1.3 – In Silico Studies of Biofilms
One method that has been used to describe how biofilms mature is referred to as
Cellular Automaton (CA), which states that the spatiotemporal variations can only have a
finite number of possible states [25]. CA biofilm models generate a wide range of
observed biofilm morphologies because they utilize a spatial lattice/grid and it is
advantageous because of this ability [25]. The Convection, Diffusion, Reaction and
Growth model (CDGR) couples CA with transport phenomena to simulate biofilm
growth in environments where fluid is flowing perpendicular to the biofilm. CDRG is a
multidimensional model that simulates biofilm maturation, and includes fluid flow over
irregular biofilm surfaces, substrate transport by convection and diffusion, substrate
consumption, and biomass growth [26]. This is done by combining dynamic equations
with CA, which governs the numbers of finite states a biofilm can assume. Boundary
conditions that govern the systems dynamics and geometry can be changed which gives
CDRG flexibility to simulate a multitude of differing scenarios [26].
A computational technique was developed at the Process Engineering Laboratory
at Massachusetts Institute of Technology (M.I.T.) by Jose Gomez, Kai Höffner, and Paul
Barton called Dynamic Flux Balance Analysis (DFBAlab) [27, 28]. DFBAlab solves
systems of differential equations which have been derived with respect to transport
phenomena, but only vary relative to time. This report will describe how transport
equations are utilized in DFBAlab to numerically calculate spatiotemporal variations
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during biofilm maturation, which is referred to as Spatiotemporal Flux Balance Analysis
(SFBA). SFBA will be used to simulate biofilm growth of P. aeruginosa by utilizing
partial differential equations coupled with a dynamic finite difference grid dependent on
the velocity of the biofilm boundary layer. SFBA incorporates solutions from FBA to
approximate the bacterial growth rate, metabolite uptake, and metabolite secretion rates
for varying compositions [27]. Concentration gradients effect the metabolic network
because it is governed by Michaelis-Menten kinetics [29, 30].
1.4 –Contributions For this Thesis
An objective of this thesis will be coupling Genome Scale Metabolic Modeling
(GSMM) and SFBA with a dynamic boundary condition relative to the biofilm expanding
and/or contracting which has never be done, and the coupling of these ideas relative to
biofilm expansion makes this thesis novel. Local optima (biomass growth rate, metabolite
uptake/secretion rates) from FBA will be used to understand the model bacterium’s
metabolic response and these parameters will govern their corresponding partial
differential equations used in SFBA. The algorithm proposed in this thesis allows for a
more accurate portrayal of the physical aspect of biofilm growth. A differential equation
that describes the biofilms length is numerically advantageous, because if the biofilm
ceases to expand and/or contract the simulation will reach a steady state relative to the
length. Spatial dependency of the finite difference grid increases spatial resolution by
dividing up the portion of the biofilm where dynamics occurs. Traditionally, the biofilm
length is defined as a constant value and space is discretized accordingly. This possesses
a problem because the dynamics occurs before and potentially after the defined points,
and when the biofilm is starting to grow points that capture the dynamics at the end of the
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biofilm are not used. Allowing the finite difference grid to change relative to the length of
the biofilm increases spatial resolution and allows this numerical method to concentrate
its computational power consistently throughout the biofilm.
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CHAPTER 2
REVIEW OF LITERATURE
2.1 –Genome Scale Metabolic Modeling for Flux Balance Analysis
Bacterium’s metabolic pathways must be defined using GSMM. This model was
taken from Genome-Scale Metabolic Network Analysis of the Opportunistic Pathogen
Pseudomonas aeruginosa for P. aeruginosa [31, 32]. FBA is “solved” by constructing a
metabolite stoichiometric matrix and used in a Linear Programming (LP) software. LPs
are systems of algebraic equations that can take continuous (mixed integer) or discrete
(integer) values [33, 34]. Growth rate and metabolite fluxes are continuous because of
how they are used to scale the governing partial differential equations (Equations 5,6).
For example, on average a typical bacterium’s mass is 1x10-12 grams and depending on
the volume under study the density will fluctuate [35]. The LP is solved and the solutions
are governed by the cells mass balance which are then used to scale local concentrations.
The mass balance was constructed using P. aeruginosa’s metabolic pathways and was
mathematically described by the following equation [36].
𝑑𝐶
=
𝑑𝑡

𝜆, 𝜈

(1)

Equation 1 is a mass balance that can be written for each metabolite (i) in a metabolic
pathway. Metabolic pathways consume metabolites produced as a part of metabolic
cycles; this is accounted for on the right-hand side (RHS) of Equation 1 by summing over
all reactions (r) that produce or consume the metabolite. Metabolite fluxes (ν j) are scaled
by the stochiometric coefficient (λi,j) relative to the specific reaction (j) in the metabolic
pathway. Given this information a system of differential equations can be constructed
with respect to the metabolic pathways.
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𝑑𝑋
= 𝑆𝜈 − 𝑏
𝑑𝑡

(2)

Equation 2 represents the time differential mass balance of an organism’s metabolic
pathway. This time derivative is set equal to zero stating that the consumption or
production of metabolites during the bacteria’s metabolic pathway is time independent
[37]. This defines the system of differential equations to be a system of algebraic
equations which can then be solved as an LP. Gurobi™ is a widely used program that
solves LPs and is done by the implementation of a biomass objective function.
0
𝑆𝜈 = 𝑏 = ⋮
0
𝐶𝜈

(3)

<𝜈 <𝜈,

(4)

𝑍=
𝜈,

Equations 2–4 are used in Gurobi™ to obtain an optimum solution to the set of algebraic
equations. Equation 3 is the biomass objective function (Z), and it is the summation of
the metabolite fluxes that are being studied in P. aeruginosa’s metabolism. The objective
function is scaled by the weight (Ci) of a particular metabolite [27].
Furthermore, once the LP has found an optimum this gives definite values for the
fluxes that maximize the growth rate. These values are consistent with the constrained
range and gave insight into how the bacteria will act under varying the maximum
metabolite uptake rates. Once FBA has found an optimal solution, the solution can then
be used as inputs to scale the differential equations that govern DFBAlab.
-7-

2.2 –Spatiotemporal Modeling of Biofilm Metabolism
SFBA utilizes partial differential equations along with the corresponding
boundary conditions to mathematically characterize biofilm growth. A variety of
boundary conditions are used such as convective mass transfer, diffusion, and “no flux”,
which are used with respect to the environment. To numerically simulate biofilm growth
these equations are spatially discretized to relieve the spatial dependency (length of the
biofilm) making the equations only time dependent.

Figure 1: A process flow diagram of Spatiotemporal Flux Balance Analysis.
Figure 1 is a process flow diagram of the algorithm that the numerical method uses to
calculate biofilm growth. SFBA uses the bacterium’s metabolic pathways defined
through GSMM to calculate parameters used to scale the spatially discretized partial
differential equations that govern biofilm growth.
Dr. Poonam Phalak in Dr. Michael Henson’s group used the fundamental
principles of continuum equations in SFBA to model chronic wound biofilm consortium.
This spatiotemporal modeling of biofilm metabolisms with P. aeruginosa and
Staphylococcus aureus (S. aureus) predicted individual species metabolism and
interspecies interaction spatiotemporally with genome-scale resolution [38]. Therefore,
-8-

SFBA should be chosen when simulating biofilms that are spatiotemporally dependent,
and this thesis adds another level of accuracy to the algorithm by prediction of the
biofilm thickness as a function of time as opposed to specifying a constant thickness a
priori as in previous work within the Henson group [37, 38, 39, 40].
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CHAPTER 3
METHODS
3.1 –Biofilm Model Formulation
Model formulation was done using reaction diffusion equations related to
transport phenomena, and this states the model does not violate continuum mechanics.
The model was derived relative to in vitro studies, and this states that at the biofilmsurface interface there is a semipermeable membrane and during expansion the biofilmair interface has no resistance to expansion (ambient air).

Figure 2: Representation of a biofilm comprised of Pseudomonas aeruginosa [32].
Figure 2 is a representation of the mature state of a biofilm, and for P. aeruginosa its
essential metabolites are glucose and oxygen [32]. These metabolites allow the bacterium
to flourish, but the bacterium has evolved to metabolize lactate and nitrate which is
prevalent to survival of the bacterium in varying environments.
𝜕𝑋
𝜕
𝜕 𝑋
= 𝜇 𝑋 − 𝜇 𝑋 − (𝑢𝑋 ) + 𝐷
𝜕𝑡
𝜕𝑧
𝜕𝑧
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(5)

𝜕𝑀
=𝜐
𝜕𝑡

𝑋 −

,

𝜕
𝑢𝑀 + 𝐷
𝜕𝑧

𝜕 𝑀
𝜕𝑧

(6)

Equations 5 and 6 are partial differential equations that describe the concentration
gradients of P. aeruginosa, glucose, oxygen, acetate, succinate, lactate, and nitrate
throughout the biofilm. The RHS of these equations are governed by the change in the
diffusive flux and the reaction terms. Equation 5 specifically describes the concentration
gradient of P. aeruginosa throughout the biofilm, and this equation accounts for growth
(𝜇 𝑋 )

and death (𝜇 𝑋 ) of the bacterium. The replication of the bacterium relies on the

growth rate (𝜇 ) and mortality relies on the death rate (𝜇 ). Equation 6 describes the
metabolites, and the production (𝜐
term ( (𝑢𝑋 ),

,

)

relies on the optimal metabolite fluxes. The next

𝑢𝑀 ) in Equations 5 and 6 describe how the velocity and velocity

gradient effects the concentration gradients. Finally, the last term (𝐷

,𝐷

)

is the

change in diffusive flux, which states that diffusion within the biofilm governs the
concentration gradients.
Another key part of the model is the boundary conditions that govern the behavior
of the equations at the boundaries.
Table 1: Boundary conditions used to govern the corresponding partial differential
equations. Each boundary condition relies on how the biomass or metabolites act at the
biofilm-surface interface (z = 0) or the biofilm-air interface (z = L) [32].

Table 1 defines the boundary conditions that govern the partial differential equations at
the biofilm-surface and biofilm-air interfaces. Starting at the initial length (z = 0) the no
flux boundary condition is applied to P. aeruginosa (Xl) because the membrane is
impermeable to cells. The metabolites boundary conditions at the biofilm-surface
- 11 -

interface are governed by convective mass transfer, diffusion, and velocity. Metabolites
can penetrate the membrane, and this is equal to the convective mass transfer, change in
diffusive flux through the biofilm and these are scaled by the velocity of the biofilm
boundary layer. At the biofilm-air interface (z = L) P. aeruginosa and the metabolites
boundary conditions are the same and represent how the velocity of the boundary layer is
governed by diffusion and convective mass transfer.
3.2 – Simulation of Biofilm Expansion
Classically the implementation of finite difference is based on defining the area of
interest, and in the case of a biofilm it is the length. Without physical knowledge of a
biofilm’s length, this proposes a problem because biofilms expand and contract stating
that the length is not constant. Incorporating a differential equation that describes the
expansion and contraction of the biofilm was done to gain another level of accuracy.
𝑑𝑢 (𝜇 𝑋 − 𝜇 𝑋 )
=
𝑑𝑧
𝜌
𝑑𝐿
= 𝑢(𝑡, 𝑧)
𝑑𝑡
𝐿(𝑧, 𝑡 ) = 𝐿

(7)
(8)
(9)

Equation 7 describes how the velocity changes throughout the length of the biofilm
which is dependent on the local concentration of biomass, growth, and death rate of P.
aeruginosa. Upon spatial discretization Equation 7 becomes algebraic and is solved
simultaneously and the solution is substituted into Equation 8. Equation 8 is then
integrated with the system of discretized partial differential equations, ultimately
calculating a new length relative to the time interval [32]. Equation 8 is defined as an
initial value problem and is governed by the length of the biofilm, which is defined at the
starting of the simulation (Equation 9). Once the simulation is executed relative to the
- 12 -

first time step the initial condition is updated by the solution (Equation 8) and the biofilm
is spatially re-discretized,

Figure 3: A edited pictorial representation of SFBA utilizing a dynamic finite difference
grid. A Classical representation of finite difference being applied to biofilm maturation. B
Novel simulation approach to numerically simulate biofilm maturation [41].
Figure 3A represents how a classical finite difference, and dynamic finite difference
(Figure 3B) can be applied to numerically simulate biofilm maturation. Comparing these
two methods reveals an obvious advantage based on how space is discretized. Classically
the amount of spatial discretization points is fixed over a certain area, and this poses an
issue pertaining to the accuracy of the dynamical nature that exists between these points.
Thinking of how the governing equations are spatially discretized this implies that during
the maturation process not all the equations are used, making the numerical simulation
less accurate. Now looking at the dynamic finite difference it shows that space where
dynamical growth is taking place is “fully” discretized and this will inherently increase
accuracy based on the smaller spatial resolution. Another key characteristic of this model
is updating the amount of growth that has taken place with the solution to Equation 8.
- 13 -

Figure 4: A process flow diagram of Spatiotemporal Flux Balance Analysis that utilizes a
dynamic boundary.
Figure 4 is a process flow diagram of the complete algorithm of SFBA with a variable
finite difference grid. Initially the user defines the initial concentrations of P. aeruginosa,
metabolites, initial biofilm length, simulation time, and number of discretization points.
A total of 20 discretization points were chosen because it enhanced spatial resolution and
adding more points was inconsequential. Simulation times were all chosen to be between
75 and 150 hours, and these were chosen to make sure the biofilm had reached a mature
state (pseudo-steady state).
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Table 2: Summary of spatiotemporal flux balance analysis parameters used to simulate
biofilm maturation with a dynamic finite difference grid [39, 42].
Parameter

Description

Value

Units

tSIM

Final Simulation Time

75 - 150

hours

Specified

tstep

Time Step Interval

1.0

hour

Specified

Npoints

Number of Spatial Discretization Points

20.0

N/A

Specified

L0

Initial Biofilm Length

1.0

µm

Specified

u0
µd

Initial Velocity
Pseudomonas aeruginosa Death Rate

0.0
0.01

µm/hour Specified
1/hour
Fitted

ρcell
[X]0

Cell Density
Initial Pseudomonas aeruginosa Concentration Applied at the Biofilm-Surface Interface

200.0
1.0

g/L
Fitted
mmol/L Specified

[G]b

Bulk Glucose Concentration Applied at the Biofilm-Surface Interface

< 20.0, 20.0 , 2.0, 2.0 >

mmol/L Specified

[O]b

Bulk Oxygen Concentration Applied at the Biofilm-Air Interface

Reference

< 0.21, 0.09, 0.21 0.09 > mmol/L Specified
2
cm /s Specified
1.00E-10
2
cm
/s
9.40E-06
[39]

DX

Pseudomonas aeruginosa Diffusion Coefficient

DG

Glucose Diffusion Coefficient

DO

Oxygen Diffusion Coefficient

2.68E-05

cm /s

DA

Acetate Diffusion Coefficient

1.62E-06

cm /s

DS

Succinate Diffusion Coefficient

1.26E-06

cm /s

2
2
2
2

[39]
Specified
Specified

DL

Lactate Diffusion Coefficent

3.54E-06

cm /s

DN

Nitrate Diffusion Coefficent

1.70E-05

cm /s

Specified

km,G

Glucose Mass Transfer Coefficient

2.00E-04

cm/s

Specified

km,O

Oxygen Mass Transfer Coefficient

2.00E-02

cm/s

Specified

km,A,S

Acetate and Succinate Mass Transfer Coefficient

5.00E-04

cm/s

Specified

km,L,N

Lactate and Nitrate Mass Transfer Coefficient

2.00E-03

cm/s

Specified

2

[42]

Table 2 are the defined parameters that were used to simulate P. aeruginosa biofilm
growth. Various parameters included in this table show benefit to utilizing SFBA with a
dynamic finite difference grid. As previously shown in Figure 4 the initial biofilm length
was specified at one micron, which encompasses the idea of the simulation starting after
the bacterium has formed a microcolony. Mathematically this means that one micron was
spatially discretized using 20 node points which increased spatial resolution.
Expansion/contraction velocity was initially set to zero to emulate reality. Parameters
such as the bulk concentrations, diffusion coefficients, and mass transfer coefficients of
the metabolites were defined to enhance biofilm growth and test the simulation based on
physical attributes to biofilm maturation. For example, the base case was considered to
have a high bulk concentration of glucose (20 mmol/L) and atmospheric dissolved
oxygen (0.21 mmol/L) with no initial concentrations of acetate, succinate, lactate, and
- 15 -

nitrate. This allows for the concentrations of glucose and oxygen to be depleted which
showed how the biofilm reacted to “starvation.” Once the base cases were studied bulk
concentrations of nitrate and lactate could be added to see how the biofilm reacted
relative to results obtained from FBA.
GSMM is governed by Michaelis-Menten kinetics, which effects the parameters
used to scale the partial differential equations. Michaelis-Menten kinetics are functions of
the local compositions of metabolites which increased accuracy.
Table 3: Summary of parameters that governed the Michaelis-Menten equation.

Table 3 summarizes the conceptual idea of FBA and gives the need for an upper bound
(ub) and lower bound (lb) to find the optima for the biomass objective function. All the
upper bounds were set to 1000 mmol/gDW/h which was defined in MATLAB™ [27].
Lower bounds were calculated and were functions of the maximum uptake (𝜐

) and

saturation rates (𝐾 ), and these parameters were taken from previous research [40, 43].
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CHAPTER 4
RESULTS AND DISCUSSION
4.1 - Metabolite Flux Analysis of Pseudomonas aeruginosa
FBA aids in understanding how the bacterium will grow relative to the metabolite
uptake. This is valuable before simulating biofilm growth using SFBA, because FBA
shows how the bacterium will react to local compositions of metabolites throughout the
biofilm. PA01 iMO1056 genome model was used for FBA [31]. Glucose and oxygen are
P. aeruginosa’s natural metabolites, and this implies that these metabolites will allow the
bacterium to replicate [32].
A

B

C

D

Figure 5: FBA results for P. aeruginosa metabolic response to glucose and oxygen
uptake. A Calculated biomass growth rate [1/h]. B Oxygen uptake rate [mmol/gDW/h]. C
Acetate secretion rate [mmol/gDW/h]. D Succinate secretion rate [mmol/gDW/h].
Figure 5 shows that P. aeruginosa’s growth rate increases and is dependent on the
oxygen and glucose uptake. Mathematically the sign of the value dictates whether the
value is an uptake rate (−) or secretion rate (+), and that is embedded in the mathematical
analysis. Determining the lower uptake bounds was not straight forward, and while
running these simulations with no oxygen and glucose the bacterium would show a
- 17 -

minuscule growth rate. Within the genomic model (PA01) the ability for the bacterium to
perform anaerobic metabolism is present via nitrate, but no nitrate was being supplied
during these simulations [31]. This simulation showed that glucose was always
completely metabolized, and the bacterium limited the metabolization of oxygen
according to glucose uptake shown in Figure 5B. Prior studies done by Dr. Poonam
Phalak and Dr. Michael Henson has shown that P. aeruginosa produces acetate and
succinate as metabolic byproducts [39]. The study showed that acetate and succinate is
produced in anaerobic environments shown in Figures 5C-5D. These results coincide
with literature and show that when P. aeruginosa is in an anaerobic environment the
bacterium produces acetate and succinate via pyruvate fermentation [44, 45, 46].
FBA utilizing glucose and oxygen uptake is the base case in this study because of
P. aeruginosa’s “natural” metabolic pathways. However, P. aeruginosa has shown
nutrient diversity based on its ability to evolve to survive in its current environment [47,
48, 49]. The first evolutionary step that was studied was the ability for the bacterium to
metabolize lactate (carbon source) [50].
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B

A

C

D

Figure 6: FBA results for P. aeruginosa metabolic response to glucose, lactate, and
oxygen uptake. A Calculated biomass growth rate [1/h]. B Lactate uptake rate
[mmol/gDW/h]. C Acetate secretion rate [mmol/gDW/h]. D Succinate secretion rate
[mmol/gDW/h].
Figure 6 shows how the bacterium reacted to glucose and lactate uptake at a constant
oxygen uptake rate (-20 mmol/gDW/h). Minimally, increasing the amount of carbon
sources should increase the total biomass growth rate. This phenomenon is shown in
Figure 6A, and portrays the bacterium and FBA is behaving according to previous studies
[48]. Lactate uptake was always maximized to the bound which shows that the bacterium
has evolved relative to glucose poor environments. Now in question is the ability for the
bacterium to produce acetate and succinate as metabolic byproducts. Figures 6C-6D show
that lactate has an inversely affected anerobic production of acetate and made succinate
production cease.
Finally, the last variation studied relative to P. aeruginosa’s evolutionary
advantage is the metabolism of nitrate [51, 52]. This studied was aimed to understand
how the bacterium reacted under anerobic environments.
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A

B

C

D

Figure 7: FBA results for P. aeruginosa metabolic response to glucose, nitrate, and
oxygen uptake. A Calculated biomass growth rate [1/h]. B Nitrate uptake rate
[mmol/gDW/h]. C Acetate secretion rate [mmol/gDW/h]. D Succinate secretion rate
[mmol/gDW/h].
Figure 7 shows how the bacterium reacted to oxygen, and nitrate uptake relative to a
fixed glucose uptake (-10 mmol/gDW/h). Specifically, the biomass growth rate increased
with the maximum oxygen and nitrate uptake rate bounds. Figure 7B shows that the
bacterium will uptake all available nitrate and is not reliant on oxygen uptake. Nitrate
uptake during low oxygen uptake states the bacterium will replicate in low oxygen
environments. Figures 7C-7D show the acetate and succinate secretion rate, and these
rates follow the same trend, but the secretion rates increased due to P. aeruginosa’s
metabolic pathways.
4.2 - Pseudomonas aeruginosa Biofilm Growth
The main objective of this thesis is to use SFBA with a finite difference grid that
varied spatiotemporally. The equations and algorithm have been previously stated, and
these results were simulated with parameters that are included in Table 2 and Table 3.
- 20 -

SFBA simulations were done with the notion of reaching a pseudo-steady state
concentration of biomass and metabolites throughout the biofilm. This aided in
understanding how the concentration of biomass and metabolites varied with time and
behaved at the two boundaries.
A

B

C

D

E

F

Figure 8: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose and oxygen concentrations ([G]B = 20 mmol/L [O2]B = 0.21
mmol/L, [G]B = 20 mmol/L [O2]B = 0.09 mmol/L, [G]B = 2 mmol/L [O2]B = 0.21 mmol/L,
[G]B = 2 mmol/L [O2]B = 0.09 mmol/L) respectively. A P. aeruginosa biofilm-surface
interface temporal concentration [g/L]. B P. aeruginosa biofilm-air interface temporal
concentration [g/L]. C Variations in axial velocity at biofilm-surface interface [μm/h]. D
Variations in axial velocity at biofilm-air interface [μm/h]. E Glucose temporal
concentration at biofilm-surface interface [mmol/L]. F Glucose temporal concentration at
biofilm-air interface [mmol/L].
Figure 8 are results of biofilm simulation over a duration of 75 hours, and this simulation
time was chosen for reassurance of reaching a pseudo-steady state (mature biofilm). Two
sections of the biofilm were plotted to show how the metabolites and axial velocity of the
boundary behaved, and four different supplied concentrations of glucose and oxygen at
the boundaries were simulated. Figure 8A-8B are simulated results of the biomass
concentration at the biofilm-surface and biofilm-air interface, respectively. Both plots
- 21 -

show exponential growth in biomass during the first 10 hours of simulation which is
directly correlated with the metabolization of glucose and oxygen. Axial velocity of the
biofilm boundary was calculated using Equation 8. Figure 8C is how the axial velocity
behaved at the biofilm-surface interface, which is governed by the no flux boundary
condition. Figure 8D shows that the biofilm showed peak expansion during the first ten
hours, and then started to decrease as the biomass reached steady state. Behavior of
biomass and velocity should be governed by the local concentrations of glucose and
oxygen at the boundaries and throughout the biofilm. Figure 8E-8F shows how glucose is
consumed over the duration of the simulation at the boundary. Both plots show that
glucose is consumed during the first 10 hours, except at the biofilm-surface interface with
high bulk concentrations (20 mmol/L).
A

B

C

D

E

F

Figure 9: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose and oxygen concentrations. A Oxygen temporal concentration
at the biofilm-surface interface [mmol/L]. B Oxygen temporal concentration at the
biofilm-air interface [mmol/L]. C Acetate temporal concentration at the biofilm-surface
interface [mmol/L]. D Acetate temporal concentration at the biofilm-air interface
[mmol/L]. E Succinate temporal concentration at the biofilm-surface interface [mmol/L].
F Succinate temporal concentration at the biofilm-air interface [mmol/L].
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Figure 9 contains the simulation results of oxygen, acetate, and succinate. Figures
9A-9B show the concentration gradients of oxygen throughout the simulation.
Specifically, Figure 9A shows that oxygen is completely depleted and is not dependent
on the bulk glucose concentration. Oxygen depletion explains why glucose was not fully
consumed at the biofilm-surface interface in Figure 8E. Figures 9C-9F show that acetate
and succinate were produced when the local composition of oxygen was low in the
biofilm which corresponds to simulation results from FBA.
The spatiotemporal variation for the axial velocity governs the dynamic finite
difference grid, and this implies that the biofilm thickness is calculated after every time
step within the simulation. Figure 10 shows that the bulk concentration of glucose is the
determining factor for the maximization of biofilm thickness. It also shows that having a
higher bulk concentration of oxygen allows for the biofilm to become thicker but is less
significant compared to glucose.
A

B

C

Figure 10: SFBA predictions of biofilm thickness for different supplied glucose and
oxygen concentrations. A Biofilm thickness after a fifty-hour simulation. B Biofilm
thickness after the first twenty hours of simulation. C Pseudo-steady state biofilm
thicknesses at fifty hours for varying bulk concentrations of glucose and oxygen.
- 23 -

Figures 8-10 have shown how the velocity, biomass, and metabolites have varied
with respect to time. These analyses do not show spatial variations within the biofilm.
Therefore, the velocity, biomass concentrations, and metabolite concentrations were
plotted as a function of position.
A

B

C

D

F

E

Figure 11: SFBA predictions of spatial gradients for different supplied glucose and
oxygen concentrations. A Spatial biomass concentrations [g/L]. B Axial velocities
[μm/h]. C Spatial concentration of glucose [mmol/L]. D Spatial concentration of oxygen
[mmol/L]. E Spatial concentration of acetate [mmol/L]. F Spatial concentration of
succinate [mmol/L].
Specifically, the noticeable difference in Figure 11 is during high and low bulk glucose
concentrations. When glucose is in excess P. aeruginosa concentration decreases slightly
as the biofilm length increases, and when glucose is not in excess P. aeruginosa’s
concentration increases as the biofilm thickens. This is because the concentration of the
essential metabolites and where they are prominent. Glucose is supplied at the base
(Position = 0) and this metabolite is the essential carbon containing compound that is
oxidized, and for the case of high glucose concentration the bacterium metabolizes the
oxygen at a higher rate. On the other hand, when the glucose bulk concentration is low,
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we see an increase in the concentration of P. aeruginosa, and this is due to the ability to
completely metabolize glucose throughout the biofilm.
FBA was used to calculate the parameters that served as inputs to scale the
discretized partial differential equations. Figure 12 are the calculated parameters as a
function of position in the biofilm. Figure 12A shows that the biomass growth rate never
becomes zero which implies the bacterium is always growing, because of local growth
through the combined uptake of glucose and oxygen. Figure 12B states that glucose does
not limit the ability for the bacterium to replicate and growth is reliant on oxygen uptake.
Figures 12D-12E follow the same trend as FBA, which when oxygen uptake is limited
the secretion rate of acetate and succinate are maximized.

A

C

B

D

E

Figure 12: SFBA predictions for the calculated growth rate and metabolite fluxes relative
to the position in the biofilm for different supplied glucose and oxygen concentrations A
Spatially distributed biomass growth rate [1/h]. B Spatially distributed glucose uptake
rate [mmol/gDW/h]. D Spatially distributed oxygen uptake rate [mmol/gDW/h]. E
Spatially distributed acetate secretion rate [mmol/gDW/h]. F Spatially distributed
succinate secretion rate [mmol/gDW/h].
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FBA predicted that P. aeruginosa can replicate via the metabolization of glucose
and lactate. This phenomenon was also studied using SFBA governed by a dynamic finite
difference grid.
A

C

E

B

D

F

Figure 13: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose, lactate, and oxygen concentrations ([G]B = 20 mmol/L [L]B =
10 mmol/L, [G]B = 20 mmol/L [L]B = 1.0 mmol/L, [G]B = 2.0 mmol/L [L]B = 10 mmol/L,
[G]B = 2.0 mmol/L [L]B = 1.0 mmol/L) respectively. A P. aeruginosa biofilm-surface
interface temporal concentration [g/L]. B P. aeruginosa biofilm-air interface temporal
concentration [g/L]. C Variations in axial velocity at biofilm-surface interface [μm/h]. D
Variations in axial velocity at biofilm-air interface [μm/h]. E Glucose temporal
concentration at biofilm-surface interface [mmol/L]. F Glucose temporal concentration at
biofilm-air interface [mmol/L].
Figure 13 contains 150-hour simulation results for varying the supplied concentrations of
glucose and lactate, while holding the bulk oxygen concentration constant

(0.21

mmol/L). Figure 13A shows that the concentration of lactate has a negligible effect
compared to glucose at the biofilm-surface interface. Biomass at the biofilm-air interface
(Figure 13B) shows that lactate is inconsequential on the pseudo-steady state biomass
concentration. Axial velocity and glucose show the same trends at both interfaces as the
previous simulation (Figures 13C-13F).
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A

B

C

D

E

Figure 14: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose, lactate, and oxygen concentrations. A Oxygen temporal
concentration at the biofilm-surface interface [mmol/L]. B Oxygen temporal
concentration at the biofilm-air interface [mmol/L]. C Lactate temporal concentration at
the biofilm-surface interface [mmol/L]. D Lactate temporal concentration at the biofilmair interface [mmol/L]. E Biofilm thickness after a 150-hour simulation.
Figure 14 are the simulated results of oxygen, lactate, and biofilm thickness.
Comparing Figure 9A to Figure 14A the consumption of oxygen in the presence of
lactate at the biofilm-surface interface is depleted at the same rate and is not specifically
dependent on the concentrations of glucose. Figure 9B and Figure 14B shows that the
presence of lactate aids in oxygen consumption at the biofilm-air interface. Figures 14C14D shows that lactate is not completely consumed until an excess of oxygen is available
(biofilm-air interface). The biomass growth rate increased by increasing glucose and
lactate uptake (Figure 6), and this is shown in comparing Figure 10 to Figure 13E.
Lactate is supplied at the biofilm-surface interface which caused the biofilm thickness to
increase without respect to the glucose concentration.
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Concentrations relative to the position in the biofilm were also plotted to
understand how introducing lactate effected the local concentration.
A

B

C

D

E

Figure 15: SFBA predictions of spatial gradients for different supplied glucose, lactate,
and oxygen concentrations. A Spatial biomass concentration [g/L]. B Axial velocities
[μm/h]. C Spatial concentration of glucose [mmol/L]. D Spatial concentration of oxygen
[mmol/L]. E Spatial concentration of lactate [mmol/L].
Starting with the biomass concentration, when comparing Figure 11A to Figure 15A
shows similar trends except for low glucose and low lactate bulk concentrations (purple
line). The biomass concentration is higher relative to position because of the length of the
biofilm, which increases oxygen permeability (Figure 15D). Comparing the axial velocity
from figure 11B to figure 15B shows that the bulk concentration of glucose determines
the axial velocities behavior. Another noticeable difference was the local oxygen
concentration throughout the biofilm. Figure 11C and Figure 15D show a similar trend
when oxygens concentration is depleted. Lastly, the concentrations of lactate showed
linear profiles, which mathematically stated the gradients are governed by diffusion [32].
Bulk concentrations of lactate increased the magnitude throughout the biofilm, but the
trends were similar regarding diffusional limitations.
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The last evolutionary advantage studied was supplying nitrate at the biofilmsurface interface. As before these results will be compared to the base case to see how
this metabolite altered biofilm maturation,
A

C

E

B

D

F

Figure 16: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose, nitrate, and oxygen concentrations ([O2]B = 0.21 mmol/L [N]B
= 0.01 mmol/L, [O2]B = 0.09 [N]B = 0.1 mmol/L, [O2]B = 0.21 [N]B = 0.02 mmol/L, [O2]B
= 0.02 [N]B = 0.02 mmol/L) respectively. A P. aeruginosa biofilm-surface interface
temporal concentration [g/L]. B P. aeruginosa biofilm-air interface temporal
concentration [g/L]. C Variations in axial velocity at biofilm-surface interface [μm/h]. D
Variations in axial velocity at biofilm-air interface [μm/h]. E Glucose temporal
concentration at biofilm-surface interface [mmol/L]. F Glucose temporal concentration at
biofilm-air interface [mmol/L].
Comparing Figure 8A to Figure 16A shows a significant increase in the biomass
concentrations from introducing nitrate. Nitrate promotes metabolism at the biofilmsurface interface and oxygen promotes metabolism at the biofilm-air interface. Axial
velocity behaves the same as the base case with no significant increase in the peak at the
biofilm-air interface. Increases in the biomass concentrations should be correlated with a
sharp depletion of glucose, however, when comparing the base case (Figures 8E-8F) to
supplying a bulk nitrate concentration (Figures 16E-16F) the glucose time profiles are
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similar. This paradox is because of the nitrate concentration profile, which is included in
Figure 17.
A

C

B

D

E

Figure 17: SFBA predictions of time variations for P. aeruginosa biofilm growth for
different supplied glucose, nitrate, and oxygen concentrations. A Oxygen temporal
concentration at the biofilm-surface interface [mmol/L]. B Oxygen temporal
concentration at the biofilm-air interface [mmol/L]. C Nitrate temporal concentration at
the biofilm-surface interface [mmol/L]. D Nitrate temporal concentration at the biofilmair interface [mmol/L]. E Biofilm thickness after a 150-hour simulation.
Throughout this study oxygen has been limited at the biofilm-surface interface which
agrees with this simulation (Figure 17A). Nitrate being supplied at the biofilm-surface
interface should aid in the consumption of glucose, but Figure 17C shows that nitrate is
consumed at the same rate of oxygen, and this explained why the time profile of glucose
were similar. Oxygen and nitrate at the biofilm-air interface (Figures 17B,17D) shows
that each metabolite is consumed relatively quickly which agrees with all the previous
results. An anomaly that did occur was in the biofilm thickness (Figure 17E) which
increases exponentially during the first period of simulation but starts to fall as the
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simulation continues. This is due to the local composition of glucose because it is the
limiting metabolite at the biofilm-air interface.
A

C

B

D

E

Figure 18: SFBA predictions of spatial gradients for different supplied glucose, nitrate,
and oxygen concentrations. A Spatial biomass concentration [g/L]. B Axial velocities
[μm/h]. C Spatial concentration of glucose [mmol/L]. D Spatial concentration of oxygen
[mmol/L]. E Spatial concentration of nitrate [mmol/L].
Figure 18 is the spatial profiles of the velocity and metabolites throughout the
biofilm relative to a supplied concentration of nitrate at the biofilm-surface interface.
Biomass concentrations at the biofilm-surface interface (Figure 18A) shows a significant
increase compared to the base case (Figure 11A), and these results coincide with previous
results. Figure 18B shows a positive steady state axial velocity for a duration of the
numerical study (≈ 10 microns) which deviated from the previous studies. This is due to
the rapid growth of P. aeruginosa which caused the boundary layer to reach a net
positive axial velocity for those specific time intervals. Figures 18C-18D show similar
profiles to the previous studies. Finally, Figure 18E depicts how the concentration
gradient of nitrate is depleted within the first 10 microns of the biofilm, which allows the
biofilm to flourish at the biofilm-surface interface.
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These studies have all shown a similar trend when viewing biofilm growth in
terms of metabolites and where they are supplied. Base cases showed that as the biofilm
expands the concentration of oxygen becomes the limiting metabolite. Introducing lactate
to the biofilm-surface interface followed a similar trend to the base case because of the
inability for glucose and lactate to be metabolized simultaneously. Furthermore,
introducing nitrate at the boundary allowed the bacterium to replicate and stay “dense” at
the interface, but as the biofilm grew cells were also limited by oxygen diffusion from the
biofilm-air interface. These result state a logical physical definition of what would alter
biofilm growth in vitro. Since these results mimic reality, they are conclusive examples
of this novel approach to incorporate GSMM and SFBA with a dynamic finite difference
to calculate the length of the biofilm to be adequate.
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CHAPTER 5
FUTURE WORK
Utilization of SFBA relative to a dynamic finite difference grid has simulated
idealistic results. P. aeruginosa’s GSMM was used to compute governing parameters
used by the governing partial differential equations. To obtain a more accurate picture of
metabolism the cell death rate could be added to FBA that is embedded within this
numerical simulation. Making the cell death rate a function of the biomass objective
function would make the model more mathematically fit. P. aeruginosa has a broad range
of metabolites as well, and it has been shown that the bacterium can metabolize acetate
and succinate. Utilizing all metabolites uptakes and using them efficiently (with respect
to computational time) is another goal that would be done via the biomass objective
function.
Additionally, adding higher dimensionality to the governing partial differential
equations would allow for an more accurate result of the concentration gradients within
the biofilm. Adding width (x) and depth (y) to the numerical simulation would allow for
the simulation to take on in vitro laboratory studies. Increasing spatial resolution would
logically coincide with similar boundary layer analyses (biofilm-air interface). To
construct a simulation in this matter the biofilm boundary layer would have a velocity in
three directions, which would add more equations that are spatially discretized and
generate a very computationally demanding biofilm model. During the construction of a
high dimensional model, data for this simulation could be obtained through in vitro
studies allowing for a more detailed comparison. In turn the in vitro data can also be
taken to support the higher dimensional model.
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